BCYC
Price
$20.09
Change
-$1.46 (-6.77%)
Updated
Sep 22, 6:59 PM EST
39 days until earnings call
CRNX
Price
$28.82
Change
-$0.35 (-1.20%)
Updated
Sep 22, 6:59 PM EST
51 days until earnings call

Compare trend and price BCYC vs CRNX

Header iconBCYC vs CRNX Comparison
Open Charts BCYC vs CRNXBanner chart's image
Bicycle Therapeutics
Price$20.09
Change-$1.46 (-6.77%)
Volume$77.24K
CapitalizationN/A
Crinetics Pharmaceuticals
Price$28.82
Change-$0.35 (-1.20%)
Volume$852.7K
CapitalizationN/A
View a ticker or compare two or three
BCYC vs CRNX Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
BCYC vs. CRNX commentary
Sep 24, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Hold and CRNX is a Hold.

COMPARISON
Comparison
Sep 24, 2023
Stock price -- (BCYC: $20.09 vs. CRNX: $28.82)
Brand notoriety: BCYC and CRNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 47% vs. CRNX: 102%
Market capitalization -- BCYC: $737.6M vs. CRNX: $1.91B
BCYC [@Biotechnology] is valued at $737.6M. CRNX’s [@Biotechnology] market capitalization is $1.91B. The market cap for tickers in the [@Biotechnology] industry ranges from $410.28B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 0 FA rating(s) are green whileCRNX’s FA Score has 0 green FA rating(s).

  • BCYC’s FA Score: 0 green, 5 red.
  • CRNX’s FA Score: 0 green, 5 red.
According to our system of comparison, CRNX is a better buy in the long-term than BCYC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 3 TA indicator(s) are bullish while CRNX’s TA Score has 6 bullish TA indicator(s).

  • BCYC’s TA Score: 3 bullish, 5 bearish.
  • CRNX’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, CRNX is a better buy in the short-term than BCYC.

Price Growth

BCYC (@Biotechnology) experienced а -3.60% price change this week, while CRNX (@Biotechnology) price change was -2.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.79%. For the same industry, the average monthly price growth was +32.38%, and the average quarterly price growth was +31.88%.

Reported Earning Dates

BCYC is expected to report earnings on Nov 02, 2023.

CRNX is expected to report earnings on Nov 14, 2023.

Industries' Descriptions

@Biotechnology (-4.79% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BCYC with price predictions.
OPEN
A.I.dvisor published
a Summary for CRNX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CRNX($1.91B) has a higher market cap than BCYC($738M). CRNX YTD gains are higher at: 57.486 vs. BCYC (-32.128). BCYC has higher annual earnings (EBITDA): -132.66M vs. CRNX (-190.89M). BCYC has more cash in the bank: 340M vs. CRNX (265M). CRNX has less debt than BCYC: CRNX (2.57M) vs BCYC (47.1M). BCYC has higher revenues than CRNX: BCYC (22.5M) vs CRNX (4.83M).
BCYCCRNXBCYC / CRNX
Capitalization738M1.91B39%
EBITDA-132.66M-190.89M69%
Gain YTD-32.12857.486-56%
P/E RatioN/AN/A-
Revenue22.5M4.83M465%
Total Cash340M265M128%
Total Debt47.1M2.57M1,836%
TECHNICAL ANALYSIS
Technical Analysis
BCYCCRNX
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 9 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 16 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
81%
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NBMOX35.360.01
+0.03%
Neuberger Berman Small Cap Growth Tr
FICCX61.64-0.04
-0.06%
Fidelity Advisor® Canada I
CAIBX62.27-0.10
-0.16%
American Funds Capital Income Bldr A
GSFPX14.53-0.03
-0.21%
Goldman Sachs US Eq Div and Premium P
TGVNX23.47-0.06
-0.25%
TCW Relative Value Mid Cap N

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with PHIO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then PHIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
-6.77%
PHIO - BCYC
41%
Loosely correlated
-0.71%
MLTX - BCYC
39%
Loosely correlated
-1.86%
ORMP - BCYC
35%
Loosely correlated
-1.14%
SAGE - BCYC
34%
Loosely correlated
-0.20%
ALPN - BCYC
34%
Loosely correlated
-2.04%
More

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with MDGL. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
-1.20%
MDGL - CRNX
51%
Loosely correlated
-3.87%
ICPT - CRNX
41%
Loosely correlated
-2.96%
CLDX - CRNX
39%
Loosely correlated
-3.01%
ORMP - CRNX
37%
Loosely correlated
-1.14%
ATRA - CRNX
35%
Loosely correlated
+0.56%
More